vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and WESBANCO INC (WSBC). Click either name above to swap in a different company.

WESBANCO INC is the larger business by last-quarter revenue ($257.2M vs $208.9M, roughly 1.2× iRhythm Holdings, Inc.). WESBANCO INC runs the higher net margin — 34.5% vs 2.7%, a 31.8% gap on every dollar of revenue. Over the past eight quarters, WESBANCO INC's revenue compounded faster (31.9% CAGR vs 25.8%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

WesBanco, Inc., is a bank holding company headquartered in Wheeling, West Virginia, United States. It has over 200 branches in West Virginia, Ohio, Western Pennsylvania, Kentucky, Maryland, and Southern Indiana.

IRTC vs WSBC — Head-to-Head

Bigger by revenue
WSBC
WSBC
1.2× larger
WSBC
$257.2M
$208.9M
IRTC
Higher net margin
WSBC
WSBC
31.8% more per $
WSBC
34.5%
2.7%
IRTC
Faster 2-yr revenue CAGR
WSBC
WSBC
Annualised
WSBC
31.9%
25.8%
IRTC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IRTC
IRTC
WSBC
WSBC
Revenue
$208.9M
$257.2M
Net Profit
$5.6M
$88.6M
Gross Margin
70.9%
Operating Margin
1.1%
Net Margin
2.7%
34.5%
Revenue YoY
27.1%
Net Profit YoY
518.5%
54.4%
EPS (diluted)
$0.18
$0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
WSBC
WSBC
Q1 26
$257.2M
Q4 25
$208.9M
$265.6M
Q3 25
$192.9M
$261.6M
Q2 25
$186.7M
$260.7M
Q1 25
$158.7M
$193.2M
Q4 24
$164.3M
$162.9M
Q3 24
$147.5M
$150.8M
Q2 24
$148.0M
$147.9M
Net Profit
IRTC
IRTC
WSBC
WSBC
Q1 26
$88.6M
Q4 25
$5.6M
$91.1M
Q3 25
$-5.2M
$83.6M
Q2 25
$-14.2M
$57.4M
Q1 25
$-30.7M
$-9.0M
Q4 24
$-1.3M
$49.6M
Q3 24
$-46.2M
$37.3M
Q2 24
$-20.1M
$28.9M
Gross Margin
IRTC
IRTC
WSBC
WSBC
Q1 26
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Operating Margin
IRTC
IRTC
WSBC
WSBC
Q1 26
Q4 25
1.1%
43.2%
Q3 25
-4.4%
39.5%
Q2 25
-10.0%
27.2%
Q1 25
-20.5%
-5.0%
Q4 24
-2.5%
38.0%
Q3 24
-34.1%
29.7%
Q2 24
-15.5%
23.7%
Net Margin
IRTC
IRTC
WSBC
WSBC
Q1 26
34.5%
Q4 25
2.7%
34.3%
Q3 25
-2.7%
31.9%
Q2 25
-7.6%
22.0%
Q1 25
-19.3%
-4.7%
Q4 24
-0.8%
30.5%
Q3 24
-31.3%
24.7%
Q2 24
-13.6%
19.5%
EPS (diluted)
IRTC
IRTC
WSBC
WSBC
Q1 26
$0.88
Q4 25
$0.18
$0.97
Q3 25
$-0.16
$0.84
Q2 25
$-0.44
$0.57
Q1 25
$-0.97
$-0.15
Q4 24
$-0.03
$0.72
Q3 24
$-1.48
$0.54
Q2 24
$-0.65
$0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
WSBC
WSBC
Cash + ST InvestmentsLiquidity on hand
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$152.7M
$4.1B
Total Assets
$1.0B
$27.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
WSBC
WSBC
Q1 26
Q4 25
$583.8M
$956.1M
Q3 25
$565.2M
$1.0B
Q2 25
$545.5M
$1.2B
Q1 25
$520.6M
$1.1B
Q4 24
$535.6M
$568.1M
Q3 24
$522.0M
$620.9M
Q2 24
$561.5M
$486.8M
Stockholders' Equity
IRTC
IRTC
WSBC
WSBC
Q1 26
$4.1B
Q4 25
$152.7M
$4.0B
Q3 25
$121.9M
$4.1B
Q2 25
$103.7M
$3.8B
Q1 25
$86.7M
$3.8B
Q4 24
$90.9M
$2.8B
Q3 24
$71.8M
$2.8B
Q2 24
$99.2M
$2.5B
Total Assets
IRTC
IRTC
WSBC
WSBC
Q1 26
$27.5B
Q4 25
$1.0B
$27.7B
Q3 25
$995.2M
$27.5B
Q2 25
$964.0M
$27.6B
Q1 25
$926.1M
$27.4B
Q4 24
$931.4M
$18.7B
Q3 24
$909.7M
$18.5B
Q2 24
$919.2M
$18.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
WSBC
WSBC
Operating Cash FlowLast quarter
$26.2M
Free Cash FlowOCF − Capex
$14.5M
FCF MarginFCF / Revenue
6.9%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
WSBC
WSBC
Q1 26
Q4 25
$26.2M
$290.4M
Q3 25
$34.9M
$116.9M
Q2 25
$27.7M
$105.0M
Q1 25
$-7.9M
$-26.4M
Q4 24
$19.2M
$211.0M
Q3 24
$24.3M
$60.7M
Q2 24
$11.8M
$18.2M
Free Cash Flow
IRTC
IRTC
WSBC
WSBC
Q1 26
Q4 25
$14.5M
$280.0M
Q3 25
$20.1M
$114.9M
Q2 25
$17.3M
$98.3M
Q1 25
$-17.3M
$-30.7M
Q4 24
$12.4M
$200.7M
Q3 24
$15.5M
$56.9M
Q2 24
$3.4M
$17.3M
FCF Margin
IRTC
IRTC
WSBC
WSBC
Q1 26
Q4 25
6.9%
105.4%
Q3 25
10.4%
43.9%
Q2 25
9.3%
37.7%
Q1 25
-10.9%
-15.9%
Q4 24
7.5%
123.2%
Q3 24
10.5%
37.7%
Q2 24
2.3%
11.7%
Capex Intensity
IRTC
IRTC
WSBC
WSBC
Q1 26
Q4 25
5.6%
3.9%
Q3 25
7.7%
0.8%
Q2 25
5.6%
2.6%
Q1 25
5.9%
2.2%
Q4 24
4.2%
6.3%
Q3 24
6.0%
2.5%
Q2 24
5.7%
0.6%
Cash Conversion
IRTC
IRTC
WSBC
WSBC
Q1 26
Q4 25
4.70×
3.19×
Q3 25
1.40×
Q2 25
1.83×
Q1 25
Q4 24
4.25×
Q3 24
1.63×
Q2 24
0.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

WSBC
WSBC

Net Interest Income$215.4M84%
Noninterest Income$41.8M16%

Related Comparisons